Caroline Tanner
Vice Chair for Clinical Research · University of California (San Francisco) School of Medicine
Credentials: · · · ·
History
Research
Review · Nature Reviews Disease Primers · 2017 · 3,946 citations
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Systematic review or meta-analysis · Neurology · 2007 · Last of 11 authors · 1,704 citations
Levodopa and the progression of Parkinson's disease
New England Journal of Medicine · 2004 · 1,358 citations
70 papers · 10 as a resident
- KM
56 papers
47 papers
46 papers
45 papers
45 papers · 1 as a resident
- LC
38 papers
- GR
36 papers
Grants
- 2018–2026
Prevention of Fractures in Patients with Parkinson's Disease
National Institute on Aging · R01
PI · $32.6M · California Pacific Med Ctr Res Institute
- 2002–2015
Continuation of NET-PD Trials at The Parkinson's Institute
National Institute of Neurological Disorders and Stroke · U10
Contact PI · $935.8K · Parkinson's Institute
- 2009–2012
Agency for Healthcare Research and Quality · R01
Contact PI · $965.9K · Parkinson's Institute
- 2005–2012
Epidemiology of Dystonia in a Multi-Ethnic Population
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $4.6M · Parkinson's Institute
Clinical trials
- 2021–2041
Parkinson Progression Marker Initiative Online (PPMI Online)
Principal investigator · Recruiting
Michael J. Fox Foundation for Parkinson's Research
- 2020–2033
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Principal investigator · Recruiting
Michael J. Fox Foundation for Parkinson's Research
- 2019–2026
Microbiota Intervention to Change the Response of Parkinson's Disease
Principal investigator · Suspended · Phase 1, Phase 2
University of California, San Francisco
- 2001
Farming and Movement Evaluation Study (FAME)
Principal investigator · Completed
National Institute of Environmental Health Sciences (NIEHS)